All lobbying filings

ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC)

Lobbying for AMERICAN PHARMACIES, INC. · Independent pharmacy services group

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income · posted Apr 22, 2026

Official filing document

Bills named in this filing 9

S 526
Pharmacy Benefit Manager Transparency Act of 2025
HR 2214
DRUG Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 4317
PBM Reform Act of 2025
S 882
Patients Before Middlemen Act
HR 5031
Preserving Patient Access to Long-Term Care Pharmacies Act
HR 3164
Ensuring Community Access to Pharmacist Services Act
S 2426
Equitable Community Access to Pharmacist Services Act
HR 2484
Seniors’ Access to Critical Medications Act of 2025

Lobbying activity 3

Pharmacy

Issues related to independent pharmacy, including insurance coverage, network, and reimbursement; S. 526, Pharmacy Benefit Transparency Act; H.R. 2214, Delinking Revenue from Unfair Gouging (DRUG) Act.

Medicare/Medicaid

Issues related to independent pharmacy, including Medicare and Medicaid reimbursement; H.R. 1, One Big Beautiful Bill Act; H.R. 4317, Pharmacy Benefit Manager (PBM) Reform Act; S. 882, Patients Before Middlemen (PBM) Act; H.R. 5031, Preserving Patient Access to Long-Term Care Pharmacies Act; H.R. 3164/S. 2426, Equitable Community Access to Pharmacist Services (ECAPS) Act; H.R. 2484, Seniors Access to Critical Medications Act; IRA Medicare Drug Price Negotiation program implementation.

Defense

TRICARE pharmacy program.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.